CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...